Moderna opens manufacturing and R&D facility in UK
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
The CSR initiative will offer Digital Radiology X-Ray service to Dholera and 33 surrounding villages in the region
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
Corning and SGD Pharma formed JV in June 2023 to expand pharmaceutical manufacturing in India
All drug substance for Moderna’s authorized Spikevax (COVID-19 mRNA vaccine) targeting the SARS-CoV-2 LP.8.1 variant is produced at the company’s facility in Laval, Quebec
This predictive technology empowers people with diabetes to take preventive action before complications arise
Subscribe To Our Newsletter & Stay Updated